Stem cell transplantation for ALL: you've always got a donor, why not always use it?
This article reviews critical current evidence and debates the potential of HSCT as a more universal treatment for ALL, reevaluating traditional treatment stratification in light of the constant availability of stem cell donors.PMID:38066901 | PMC:PMC10726989 | DOI:10.1182/hematology.2023000423
Source: Hematology ASH Education Program - Category: Hematology Authors: David Shyr Kara L Davis Alice Bertaina Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Chemotherapy | Education | Hematology | Immunotherapy | Leukemia | Pediatrics | Stem Cell Therapy | Stem Cells | Toxicology | Transplants | Universities & Medical Training